Connect your AI

Microbot Medical MBOT Operating Cash Flow

Operating Cash Flow at other companies

Intuitive SurgicalISRG

$911.9M+56.8%

MedtronicMDT

$2.57B+1.8%

AngioDynamicsANGO

-$3.11M+76.4%

ITG

Integer HoldingsITGR

$24.7M-21.0%

Merit Medical SystemsMMSI

$40.68M+0.3%

StereotaxisSTXS

-$3.44M-93.5%

Other financials

Income statement

Revenue$105.0K—

Gross profit$2.0K—

Operating income-$4.3M-43.0%

Net income-$3.7M-41.1%

EPS (diluted)-$0.05+37.5%

Balance sheet

Cash & equivalents$3.7M+13.7%

Total debt$898.0K+551%

Total equity$74.1M+156%

Total assets$78.1M+153%

Cash flow

CapEx$108.0K+731%

Free cash flow-$5.2M-78.8%

Valuation

Market cap$128.28M+36.1%

Enterprise value$125.53M+39.0%

P/S674.3×—

Profitability

Operating margin25,292.9%—

Net margin-3,669.9%—

FCF margin-852.8%—

Returns & leverage

Return on equity-27.6%-10.2pp

Debt / equity0×0.0×

Current ratio22.6×+6.4×

Where this comes from

Reported directly by Microbot Medical in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.

The official record: Microbot Medical’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Microbot Medical's operating cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Microbot Medical's operating cash flow?: Microbot Medical (MBOT) reported operating cash flow of -$5.05M in Q1 2026.
How has Microbot Medical's operating cash flow changed year-over-year?: Microbot Medical's operating cash flow decreased by 75.8% year-over-year, from -$2.87M to -$5.05M.
What is the long-term trend for Microbot Medical's operating cash flow?: Over 4 years (2021 to 2025), Microbot Medical's operating cash flow has grown at a 8.7% compound annual growth rate (CAGR), from -$9.35M to -$13.05M.
What does operating cash flow mean?: Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.